CYSTM1

Model summary

A small, single-pass membrane organizer that uses a cysteine-rich extracellular loop to assemble binding-dependent complexes controlling vesicle trafficking and cell-surface signaling. By scaffolding and routing cargo through secretory and endocytic pathways, it dampens mTORC1 pathway output and contributes to broader protein transport dynamics. Its membrane residency and packaging into extracellular vesicles position it at the plasma membrane and specialized secretory granules, where it modulates signaling by redistributing regulatory assemblies.

Predicted Gene Ontology terms

1. 01

   I begin with the InterPro architecture.

   The sequence is short and compact, with IPR043240 (Cysteine-rich and transmembrane domain-containing protein 1-like family) spanning residues 1–97 and embedding a single IPR028144 cysteine-rich transmembrane domain from residues 63–96. This layout defines a single-pass membrane protein whose defining feature is a cysteine-rich luminal/extracellular loop stabilized by disulfide bonds. Such cysteine-rich modules typically mediate avid, multivalent contacts rather than catalysis, and the absence of enzymatic motifs points toward a binding/scaffolding role. The single-pass topology and compact size favor trafficking and vesicular pathways over soluble cytosolic functions.

2. 02

   From this architecture, the molecular function resolves as protein binding (GO:0005515).

   The cysteine-rich extracellular loop provides a high-affinity interface for assembling complexes at membranes, while the short cytosolic tail can recruit trafficking adaptors. This binding-centric design causes the protein to act as a membrane-tethered organizer rather than an enzyme.

3. 03

   The biological processes follow from how this binding scaffold operates.

   First, a single-pass organizer that cycles through secretory and endocytic routes naturally participates in protein transport (GO:0015031). The cysteine-rich domain’s propensity for disulfide-stabilized interactions supports sorting and retention within vesicular pathways and at the cell surface. Second, suppression of mTORC1 signaling (GO:1904262 negative regulation of TORC1 signaling) can be mechanistically explained by membrane-localized sequestration and trafficking of pathway components. By concentrating or removing mTORC1 regulators at the plasma membrane and endolysosomal interfaces, the protein reduces pathway output.

4. 04

   Cellular localization is dictated by the membrane-anchored architecture and vesicle association.

   The single-pass design and trafficking role place the protein at the plasma membrane (GO:0005886), consistent with a cell-surface scaffold that modulates signaling. Its presence in extracellular exosomes (GO:0070062) is explained by sorting of single-pass proteins into secretory/exocytic routes and vesicle budding pathways. The annotation to tertiary granule membrane (GO:0070821) indicates routing through specialized secretory granules; this is coherent with a cysteine-rich luminal domain that stabilizes cargo within acidic vesicles. Together, these compartments align with a membrane-tethered organizer that traffics through secretory and endocytic systems.

5. 05

   Integrating these lines, a mechanistic hypothesis emerges: the cysteine-rich extracellular loop nucleates complexes that dampen mTORC1 signaling by redistributing pathway nodes between the plasma membrane and endolysosomal compartments.

   The protein likely binds and stabilizes assemblies with mTORC1 regulators (e.g., RPTOR and RHEB) and with vesicle machinery that tunes receptor and growth-factor trafficking. It may transiently associate with clathrin adaptors and small GTPases to bias endocytic flux, thereby lowering mTORC1 activation. In parallel, its membrane residence and exosome packaging position it to influence signaling both locally at the cell surface and at vesicle interfaces that govern cargo transport.